OBI Pharma Inc

Common Name
OBI Pharma
Country
Taiwan
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
Ticker
4174
Exchange
TAIPEI EXCHANGE
Description
OBI Pharma, Inc. is a biotechnology company specializing in the research and development of innovative cancer therapies. Founded in 2002 and headquartered in Taipei, Taiwan, OBI Pharma operates as a g...

OBI Pharma's GHG Emissions Data Preview

In 2022, OBI Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, OBI Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2022202120202019 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind OBI Pharma’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore OBI Pharma’s data sources below and access millions more through our Disclosure Search.

a. OBI Pharma's ESG Report 2023
a. OBI Pharma's ESG Report 2023

Insights into OBI Pharma's Operational Emissions

In 2022, the total operational greenhouse gas (GHG) emissions of OBI Pharma amounted to 577.641 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

OBI Pharma's Scope 1 Emissions Over Time

202207142128tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are OBI Pharma's Scope 1 emissions?

In 2022, the total Scope 1 emissions of OBI Pharma were 25.331 metric tons of CO₂ equivalent (tCO₂e). a

What are OBI Pharma's Scope 2 emissions?

In 2022, OBI Pharma reported Scope 2 greenhouse gas (GHG) emissions of 552.311 tCO₂e without specifying the calculation method. a

What methodology does OBI Pharma use for Scope 2 reporting?

In 2022, OBI Pharma reported its Scope 2 emissions using an unspecified methodology. a

OBI Pharma's Scope 2 Emissions Over Time

20220150300450600tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into OBI Pharma's Value Chain Emissions

In 2022, OBI Pharma reported 168.562 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2022 disclosure of OBI Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in , demonstrating consistent Scope 3 emissions reporting coverage year over year. a

OBI Pharma's Scope 3 Emissions Over Time

202204590135180tCO2e
  • Total Scope 3
  • Year-over-Year Change

What are OBI Pharma's Scope 3 emissions?

In 2022, OBI Pharma reported total Scope 3 emissions of 168.562 metric tons of CO₂ equivalent (tCO₂e). a

Insights into OBI Pharma’s GHG Emissions Intensity Compared to Industry Peers

In 2022, OBI Pharma reported Scope 1 greenhouse gas (GHG) emissions of 25.331 tCO₂e and total revenues of USD 0 millions. This translates into an emissions intensity of 165.23 tCO₂e per millions USD. a

OBI Pharma's Scope 1 Emissions Intensity Compared to Peers

51001,00020,000500,000Scope 1 Emissions (tCO2e)0.251002,000100,000Revenues (Millions of USD)Kintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscendis PharmaYear: 2024Scope 1: 62 tCO2eRevenue: $M 443Scope 1 Intensity: 0.14 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MAdimmuneYear: 2023Scope 1: 4,556 tCO2eRevenue: $M 58Scope 1 Intensity: 78.30 tCO2e/$MGubraYear: 2023Scope 1: 6 tCO2eRevenue: $M 30Scope 1 Intensity: 0.20 tCO2e/$MCSLYear: 2025Scope 1: 135,000 tCO2eRevenue: $M 23,347Scope 1 Intensity: 5.78 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MBiontechYear: 2024Scope 1: 2,405 tCO2eRevenue: $M 3,341Scope 1 Intensity: 0.72 tCO2e/$MCamurusYear: 2024Scope 1: 116 tCO2eRevenue: $M 169Scope 1 Intensity: 0.68 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MBeOne MedicinesYear: 2024Scope 1: 3,547 tCO2eRevenue: $M 27,369Scope 1 Intensity: 0.13 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MValnevaYear: 2024Scope 1: 1,277 tCO2eRevenue: $M 176Scope 1 Intensity: 7.24 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MZealand PharmaYear: 2024Scope 1: 145 tCO2eRevenue: $M 9Scope 1 Intensity: 16.60 tCO2e/$MOBI PharmaYear: 2022Scope 1: 25 tCO2eRevenue: $M 0Scope 1 Intensity: 165.23 tCO2e/$M

How does OBI Pharma's GHG emissions intensity compare to its peers?

In 2022, OBI Pharma reported a Scope 1 emissions intensity of 165.23 tCO₂e per millions USD. Compared to the peer group median of 6.23 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does OBI Pharma rank on GHG emissions intensity within its industry?

In 2022, OBI Pharma ranked 23 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places OBI Pharma among the least efficient performers, with one of the highest emissions intensities in its sector. a

Insights into OBI Pharma's Total Carbon Footprint

In 2022, OBI Pharma reported a total carbon footprint of 746.203 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. a

The largest contributor to OBI Pharma's total carbon footprint was Scope 2 emissions, accounting for 74.02% of the company's total carbon footprint, followed by Scope 3 emissions at 22.59%. a

Want Full Access to OBI Pharma's GHG Emissions Dataset?
Sign Up